Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “lung cancer”

TROP2 NMR Concordance StudyRecruiting
NCT07624318N/AUpdated Sep 9, 2026
Sponsor: AstraZeneca
Lung Cancer
China
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung CancerCompleted
NCT04838548Phase 2Updated Sep 9, 2026
Sponsor: Lepu Biopharma Co., Ltd.
Carcinoma, Non-Small-Cell Lung
China
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Recruiting
NCT04928846Phase 3Updated Sep 9, 2026
Sponsor: AbbVie
Non Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +27 more
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung CancerRecruiting
NCT07365241Phase 3Updated Sep 9, 2026
Sponsor: AbbVie
Small Cell Lung Cancer
United States, Austria, France, Germany, Greece +3 more
Study of TUB-040 in Participants With Unresectable or Metastatic Nonsquamous Non-small Cell Lung CancerNot Yet Recruiting
NCT07806773Phase 2Updated Sep 9, 2026
Sponsor: Tubulis GmbH
NSCLC · Non Small Cell Lung Cancer
United States
Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)Active Not Recruiting
NCT05925530Phase 2Updated Sep 9, 2026
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
United States, Austria, Canada, Czechia, France +6 more
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)Recruiting
NCT07554339Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Brazil, China +11 more
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)Active Not Recruiting
NCT06635824Phase 3Updated Sep 9, 2026
Sponsor: Genmab
PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
United States, Argentina, Australia, Austria, Belgium +22 more
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC PatientsActive Not Recruiting
NCT06538038N/AUpdated Sep 9, 2026
Sponsor: PrECOG, LLC.
Non Small Cell Lung Cancer · Epidermal Growth Factor Receptor Gene Mutation · Stage III Lung Cancer · Stage IV Lung Cancer
United States
A Prospective, Single-center, Non-randomized, Interventional Study on the Effectiveness and Safety of Combined Immunotargeted Therapy in Patients With Metastatic Non-small Cell Cancer With a RET Gene TranslocationRecruiting
NCT07809256Phase 3Updated Sep 9, 2026
Sponsor: EuroCityClinic LLC
NSCLC (Non-small Cell Lung Cancer)R
Russia
First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)Active Not Recruiting
NCT05361395Phase 1Updated Sep 9, 2026
Sponsor: Amgen
Extensive Stage Small Cell Lung Cancer
United States, Australia, Belgium, Canada, Denmark +10 more
A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C MutationTerminated
NCT06039384Phase 1Updated Sep 8, 2026
Sponsor: Incyte Corporation
Advanced Solid Tumors
United States, Italy, Spain, United Kingdom
Understanding the Feasibility of a Co-designed Pre-radiotherapy Exercise Programme - A Single-arm StudyRecruiting
NCT07554677NAUpdated Sep 8, 2026
Sponsor: Queen's University, Belfast
Lung Cancer
United Kingdom
HTA of NIVATS Based on RWECompleted
NCT06574295N/AUpdated Sep 8, 2026
Sponsor: Fudan University
Lung Cancer
China
A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight LossNot Yet Recruiting
NCT07663630Phase 1Updated Sep 8, 2026
Sponsor: Pfizer
Non-small Cell Lung Cancer (NSCLC) · Cachexia
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerRecruiting
NCT06119581Phase 3Updated Sep 8, 2026
Sponsor: Eli Lilly and Company
Carcinoma, Non-Small-Cell Lung · Neoplasm Metastasis
United States, Australia, Austria, Belgium, Brazil +24 more
Understanding Rural Patient and Provide Preferences for Mobile Lung Cancer Screening ClinicsSuspended
NCT04926662N/AUpdated Sep 8, 2026
Sponsor: Dartmouth-Hitchcock Medical Center
Lung Cancer
United States
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung LiningRecruiting
NCT00242723N/AUpdated Sep 8, 2026
Sponsor: National Cancer Institute (NCI)
Thoracic Cancers · Malignant Pleural Mesotheliomas NOS · Lung Cancer NOS · Esophageal Cancers NOS
United States
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or MetastaticNot Yet Recruiting
NCT07807345Phase 1Updated Sep 8, 2026
Sponsor: Sutro Biopharma, Inc.
Head & Neck Squamous Cell Carcinoma · Non-Small Cell Lung Cancer · Esophageal Cancer · Gastric Cancer
United States
ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese CohortRecruiting
NCT07808164N/AUpdated Sep 8, 2026
Sponsor: Tam Anh Research Institute
HCC - Hepatocellular Carcinoma · CRC (Colorectal Cancer) · Gastric Carcinoma · Breast Cancer
Vietnam
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])Recruiting
NCT04267848Phase 3Updated Sep 8, 2026
Sponsor: National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma · Lung Non-Small Cell Squamous Carcinoma · Lung Non-Squamous Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8
United States, Guam
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized CareRecruiting
NCT06482073N/AUpdated Sep 8, 2026
Sponsor: Mayo Clinic
Lung Carcinoma · Metastatic Malignant Neoplasm in the Lung
United States
A Clinical Trial on the Efficacy and Safety of TQB6411 for InjectionRecruiting
NCT07367529Phase 1, Phase 2Updated Sep 8, 2026
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Advanced Lung Cancer
China
18G Ultrafine Cryoablation Needle for Coaxial Biopsy and Cryoablation of Pulmonary NodulesNot Yet Recruiting
NCT07806981NAUpdated Sep 8, 2026
Sponsor: Shanghai Chest Hospital
Pulmonary Nodules
PEMBRO-K : Evaluation of Pembrolizumab Therapeutic Pharmacological Monitoring Benefit in NSCLCRecruiting
NCT06195527N/AUpdated Sep 8, 2026
Sponsor: University Hospital, Angers
Non Small Cell Lung Cancer
France

Previous page Next page